• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-27a-3p靶向FoxO信号通路以诱导胆管细胞出现肿瘤样表型。

MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.

作者信息

Duwe Lea, Munoz-Garrido Patricia, Lewinska Monika, Lafuente-Barquero Juan, Satriano Letizia, Høgdall Dan, Taranta Andrzej, Nielsen Boye S, Ghazal Awaisa, Matter Matthias S, Banales Jesus M, Aldana Blanca I, Gao Yu-Tang, Marquardt Jens U, Roberts Lewis R, Oliveira Rui C, Koshiol Jill, O'Rourke Colm J, Andersen Jesper B

机构信息

Biotech Research & Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark.

Biotech Research & Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.

出版信息

J Hepatol. 2023 Feb;78(2):364-375. doi: 10.1016/j.jhep.2022.10.012. Epub 2022 Oct 28.

DOI:
10.1016/j.jhep.2022.10.012
PMID:36848245
Abstract

BACKGROUND & AIMS: Cholangiocarcinoma (CCA) is a heterogeneous and lethal malignancy, the molecular origins of which remain poorly understood. MicroRNAs (miRs) target diverse signalling pathways, functioning as potent epigenetic regulators of transcriptional output. We aimed to characterise miRNome dysregulation in CCA, including its impact on transcriptome homeostasis and cell behaviour.

METHODS

Small RNA sequencing was performed on 119 resected CCAs, 63 surrounding liver tissues, and 22 normal livers. High-throughput miR mimic screens were performed in three primary human cholangiocyte cultures. Integration of patient transcriptomes and miRseq together with miR screening data identified an oncogenic miR for characterization. MiR-mRNA interactions were investigated by a luciferase assay. MiR-CRISPR knockout cells were generated and phenotypically characterized in vitro (proliferation, migration, colony, mitochondrial function, glycolysis) and in vivo using subcutaneous xenografts.

RESULTS

In total, 13% (140/1,049) of detected miRs were differentially expressed between CCA and surrounding liver tissues, including 135 that were upregulated in tumours. CCA tissues were characterised by higher miRNome heterogeneity and miR biogenesis pathway expression. Unsupervised hierarchical clustering of tumour miRNomes identified three subgroups, including distal CCA-enriched and IDH1 mutant-enriched subgroups. High-throughput screening of miR mimics uncovered 71 miRs that consistently increased proliferation of three primary cholangiocyte models and were upregulated in CCA tissues regardless of anatomical location, among which only miR-27a-3p had consistently increased expression and activity in several cohorts. FoxO signalling was predominantly downregulated by miR-27a-3p in CCA, partially through targeting of FOXO1. MiR-27a knockout increased FOXO1 levels in vitro and in vivo, impeding tumour behaviour and growth.

CONCLUSIONS

The miRNomes of CCA tissues are highly remodelled, impacting transcriptome homeostasis in part through regulation of transcription factors like FOXO1. MiR-27a-3p arises as an oncogenic vulnerability in CCA.

IMPACT AND IMPLICATIONS

Cholangiocarcinogenesis entails extensive cellular reprogramming driven by genetic and non-genetic alterations, but the functional roles of these non-genetic events remain poorly understood. By unveiling global miRNA upregulation in patient tumours and their functional ability to increase proliferation of cholangiocytes, these small non-coding RNAs are implicated as critical non-genetic alterations promoting biliary tumour initiation. These findings identify possible mechanisms for transcriptome rewiring during transformation, with potential implications for patient stratification.

摘要

背景与目的

胆管癌(CCA)是一种异质性且致命的恶性肿瘤,其分子起源仍知之甚少。微小RNA(miR)靶向多种信号通路,作为转录输出的有效表观遗传调节因子发挥作用。我们旨在表征CCA中miR组失调情况,包括其对转录组稳态和细胞行为的影响。

方法

对119例切除的CCA、63例周围肝组织和22例正常肝脏进行小RNA测序。在三种原代人胆管细胞培养物中进行高通量miR模拟物筛选。将患者转录组和miRseq与miR筛选数据整合,鉴定出一种致癌miR进行表征。通过荧光素酶测定研究miR与mRNA的相互作用。生成miR - CRISPR敲除细胞,并在体外(增殖、迁移、集落形成、线粒体功能、糖酵解)和体内使用皮下异种移植进行表型特征分析。

结果

总共13%(140/1049)检测到的miR在CCA和周围肝组织之间差异表达,其中135个在肿瘤中上调。CCA组织的特征是miR组异质性和miR生物合成途径表达更高。肿瘤miR组的无监督层次聚类确定了三个亚组,包括富含远端CCA和富含异柠檬酸脱氢酶1(IDH1)突变体的亚组。miR模拟物的高通量筛选发现71个miR持续增加三种原代胆管细胞模型的增殖,并且在CCA组织中上调,无论解剖位置如何,其中只有miR - 27a - 3p在几个队列中持续增加表达和活性。在CCA中,FoxO信号主要被miR - 27a - 3p下调,部分是通过靶向FOXO1。miR - 27a敲除在体外和体内增加FOXO1水平,阻碍肿瘤行为和生长。

结论

CCA组织的miR组高度重塑,部分通过调节FOXO1等转录因子影响转录组稳态。miR - 27a - 3p成为CCA中的致癌弱点。

影响与意义

胆管癌发生需要由遗传和非遗传改变驱动的广泛细胞重编程,但这些非遗传事件的功能作用仍知之甚少。通过揭示患者肿瘤中全局miRNA上调及其增加胆管细胞增殖的功能能力,这些小非编码RNA被认为是促进胆管肿瘤发生的关键非遗传改变。这些发现确定了转化过程中转录组重新布线的可能机制,对患者分层具有潜在意义。

相似文献

1
MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.微小RNA-27a-3p靶向FoxO信号通路以诱导胆管细胞出现肿瘤样表型。
J Hepatol. 2023 Feb;78(2):364-375. doi: 10.1016/j.jhep.2022.10.012. Epub 2022 Oct 28.
2
Decoding the role of novel long noncoding RNAs lnc-SLC6A12-1:3 and lnc-SLC6A12-7:5 in regulating the expression of GAD1 and SLC6A12 in cholangiocarcinoma.解码新型长链非编码RNA lnc-SLC6A12-1:3和lnc-SLC6A12-7:5在调节胆管癌中GAD1和SLC6A12表达方面的作用。
Comput Biol Chem. 2025 Jun 20;119:108562. doi: 10.1016/j.compbiolchem.2025.108562.
3
Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.肝细胞核因子6通过调控miR-122抑制胆管癌细胞的生长和转移。
J Cancer Res Clin Oncol. 2016 May;142(5):969-80. doi: 10.1007/s00432-016-2121-8. Epub 2016 Jan 29.
4
Negative energy balance by feed deprivation affects the adipose miRNome in the lactating goat.通过饲料剥夺造成的负能量平衡会影响泌乳山羊的脂肪组织微小RNA组。
J Anim Sci. 2025 Jan 4;103. doi: 10.1093/jas/skaf044.
5
CAFs exosomal circFOXO1 promotes TNBC autophagy and radioresistance via miR-27a-3p/BNIP3 axis.癌症相关成纤维细胞外泌体环状FOXO1通过miR-27a-3p/BNIP3轴促进三阴性乳腺癌的自噬和放射抗性。
Sci Rep. 2025 Aug 10;15(1):29273. doi: 10.1038/s41598-025-13876-6.
6
Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.揭示坏死性凋亡微环境的作用:FCGBP+肿瘤相关巨噬细胞驱动原发性肝癌向胆管细胞型肝细胞癌或肝内胆管癌分化。
Apoptosis. 2024 Apr;29(3-4):460-481. doi: 10.1007/s10495-023-01908-3. Epub 2023 Nov 28.
7
Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution.以单细胞分辨率解析肝外胆管癌的胆管癌异质性和特定祖细胞生态位。
J Hematol Oncol. 2025 Jun 23;18(1):66. doi: 10.1186/s13045-025-01716-z.
8
A novel long non-coding RNA, PICSAR, promotes thyroid cancer progression through the hsa-miR-320A/hsa-miR-485/RAPGEFL1 axis.一种新型长链非编码RNA,PICSAR,通过hsa-miR-320A/hsa-miR-485/RAPGEFL1轴促进甲状腺癌进展。
Med Oncol. 2025 Aug 26;42(10):448. doi: 10.1007/s12032-025-02987-9.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
Gene Coexpression and miRNA Regulation: A Path to Early Intervention in Colorectal Cancer.基因共表达和 miRNA 调控:结直肠癌早期干预的途径。
Hum Gene Ther. 2024 Oct;35(19-20):855-867. doi: 10.1089/hum.2023.207. Epub 2024 Jul 4.

引用本文的文献

1
Exosomal Liquid Biopsy for the Early Detection of Gastric Cancer: The DESTINEX Multicenter Study.用于胃癌早期检测的外泌体液体活检:DESTINEX多中心研究
JAMA Surg. 2025 Jul 30. doi: 10.1001/jamasurg.2025.2493.
2
MicroRNAs in Systemic Sclerosis: Involvement in Disease Pathogenesis and Potential Use as Diagnostic Biomarkers and Therapeutic Targets.系统性硬化症中的微小RNA:参与疾病发病机制及作为诊断生物标志物和治疗靶点的潜在用途。
Biomedicines. 2025 May 16;13(5):1216. doi: 10.3390/biomedicines13051216.
3
The Small RNA Landscape in Azoospermia: Implications for Male Infertility and Sperm Retrieval-A Preliminary Study.

本文引用的文献

1
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.欧洲胆管癌全景:ENSCCA 注册中心的诊断、预后和治疗见解。
J Hepatol. 2022 May;76(5):1109-1121. doi: 10.1016/j.jhep.2021.12.010. Epub 2022 Feb 12.
2
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.上皮细胞对炎症的记忆在限制组织损伤的同时促进了胰腺肿瘤的发生。
Science. 2021 Sep 17;373(6561):eabj0486. doi: 10.1126/science.abj0486.
3
miRNA activity inferred from single cell mRNA expression.
无精子症中的小RNA格局:对男性不育和精子获取的影响——一项初步研究
Int J Mol Sci. 2025 Apr 9;26(8):3537. doi: 10.3390/ijms26083537.
4
MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation.MET通过促进TRIB3介导的FOXO1降解来促进肝细胞癌的发展。
Clin Mol Hepatol. 2025 Jul;31(3):1032-1057. doi: 10.3350/cmh.2024.1163. Epub 2025 Apr 11.
5
Targeting Glycolytic Reprogramming in Cholangiocarcinoma: A Novel Approach for Metabolic Therapy.靶向胆管癌中的糖酵解重编程:代谢治疗的新方法
J Inflamm Res. 2024 Nov 25;17:9665-9681. doi: 10.2147/JIR.S497551. eCollection 2024.
6
CircRNA_SLC8A1 alleviates hypertrophic scar progression by mediating the Nrf2-ARE pathway.环状 RNA_SLC8A1 通过介导 Nrf2-ARE 通路缓解增生性瘢痕进展。
Mol Biol Rep. 2024 Oct 18;51(1):1067. doi: 10.1007/s11033-024-10018-5.
7
ZNF460-mediated upregulation of APCDD1L-DT promotes cholangiocarcinoma development by inhibiting the ubiquitin-mediated degradation of DVL2.ZNF460 通过介导 APCDD1L-DT 的上调抑制 DVL2 的泛素化降解促进胆管癌的发展。
Cancer Gene Ther. 2024 Oct;31(10):1585-1597. doi: 10.1038/s41417-024-00826-z. Epub 2024 Aug 30.
8
SIRT1 silencing ameliorates malignancy of non-small cell lung cancer via activating FOXO1.沉默 SIRT1 通过激活 FOXO1 改善非小细胞肺癌的恶性程度。
Sci Rep. 2024 Aug 28;14(1):19948. doi: 10.1038/s41598-024-70970-x.
9
Fetal Brain-Derived Exosomal miRNAs from Maternal Blood: Potential Diagnostic Biomarkers for Fetal Alcohol Spectrum Disorders (FASDs).胎儿血源性外泌体 miRNAs 作为胎儿酒精谱系障碍(FASDs)的潜在诊断生物标志物。
Int J Mol Sci. 2024 May 27;25(11):5826. doi: 10.3390/ijms25115826.
10
Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice.在糖尿病前期小鼠中,慢性恩格列净导致的肾脏细胞代谢、结构和功能的新生变化。
Am J Physiol Cell Physiol. 2024 Apr 1;326(4):C1272-C1290. doi: 10.1152/ajpcell.00446.2023. Epub 2024 Mar 4.
从单细胞 mRNA 表达推断 miRNA 活性。
Sci Rep. 2021 Apr 28;11(1):9170. doi: 10.1038/s41598-021-88480-5.
4
Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.整合分析揭示了在胆管内乳头状和管状乳头状胆管癌发生过程中早期且独特的遗传和表观遗传变化。
Gut. 2022 Feb;71(2):391-401. doi: 10.1136/gutjnl-2020-322983. Epub 2021 Jan 19.
5
Therapeutic advances of miRNAs: A preclinical and clinical update.微小RNA的治疗进展:临床前与临床最新情况
J Adv Res. 2020 Aug 29;28:127-138. doi: 10.1016/j.jare.2020.08.012. eCollection 2021 Feb.
6
Multi-omics analysis identifies FoxO1 as a regulator of macrophage function through metabolic reprogramming.多组学分析鉴定 FoxO1 通过代谢重编程调控巨噬细胞功能。
Cell Death Dis. 2020 Sep 24;11(9):800. doi: 10.1038/s41419-020-02982-0.
7
miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis.胆管上皮内瘤变的 miRNA 图谱通过 miR-451a/ATF2 轴揭示远端胆管癌的逐步肿瘤发生。
J Pathol. 2020 Nov;252(3):239-251. doi: 10.1002/path.5514. Epub 2020 Sep 15.
8
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.胆管癌 2020:机制和管理的新前沿。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30.
9
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.肝外胆管癌的分子分类与治疗靶点
J Hepatol. 2020 Aug;73(2):315-327. doi: 10.1016/j.jhep.2020.03.008. Epub 2020 Mar 12.
10
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.